The Biden administration asked for a review of mifepristone access by the Supreme Court, leading to a decision to halt restrictions.

RELATED: Abortion pill access under scrutiny after Roe v Wade overturned https://bit.ly/40p9iYA

The Supreme Court on Friday allowed full access to the abortion pill mifepristone, resolving for now a massive and fast moving conflict over the drug while the underlying lawsuit is decided.

Of immediate significance were restrictions on access to mifepristone that were set to take effect at midnight, including a requirement that Americans sit for in-person visits with doctors and a prohibition on the drug being dispensed through the mail. The Food and Drug Administration lifted those restrictions through a series of actions since first approving the drug in 2000 but a federal appeals court had put them back in place.

The Supreme Court’s decision Friday means those restrictions will not be imposed and the drug will remain available as it was prior to a series of court orders limiting access to it. As is often the case in emergency appeals, the court did not explain its reasoning.

» Subscribe to USA TODAY: http://bit.ly/1xa3XAh
» Watch more on this and other topics from USA TODAY: https://bit.ly/3Il7OJE
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.

#Abortion #SupremeCourt #AbortionPill